Question from Deputy Ken O'Flynn - PQ 28186-26
Deputy O'Flynn asked the number of outpatient non-attendance cases attributed to transport issues since Jan 2025. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Flynn asked the number of outpatient non-attendance cases attributed to transport issues since Jan 2025. Read the HSE response.
Deputy O'Flynn asked about mechanisms that are in place to monitor rejection rates for commonly prescribed medicines. Read the HSE response.
Deputy O'Flynn asked about any audit or validation exercise has been conducted on the accuracy/consistency of claim rejections by PCRS. Read the HSE response.
Deputy O'Flynn asked for a detailed breakdown of reasons for rejected/unpaid pharmacy claims under the general medical services scheme. Read the HSE response.
Deputy O'Flynn asked about the treatment abroad scheme records total cost per patient episode since 2020. Read the HSE response.
Deputy O'Flynn asked for the public healthcare providers abroad to which minors have been referred for gender-related services. Read the HSE response.
Deputy O'Flynn asked about the average waiting time from referral to first assessment and from assessment to intervention in CDNTs. Read the HSE response.
Deputy O'Flynn asked if PCRS maintains product-specific data on rejected or unpaid pharmacy claims. Read the HSE response.
Deputy O'Flynn asked if rejected/unpaid claims for salbutamol nebules (2024/25) can be disaggregated from general rejection categories. Read the HSE response.
Deputy O'Flynn asked the policy basis upon which referrals of minors for gender-related treatment abroad continue to be authorised. Read the HSE response.